AHA 2020: RIVER Shows Rivaroxaban Safe for Patients with Bioprosthetic Valves

Healthed

Results from the RIVER trial reveal important new information for the treatment of atrial fibrillation in patients with bioprosthetic mitral valves.

Read the Original Article>>

Source: Duke Clinical Research Institute

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Healthed

expert

Healthed

Recent Articles

Share this